Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
Open accessAbstract
Binge eating disorder (BED) is the most common eating disorder and an important public health problem. It is characterized by recurrent episodes of excessive food consumption accompanied by a sense of loss of control over the binge eating behavior without the inappropriate compensatory weight loss behaviors of bulimia nervosa. BED affects both sexes and all age groups and is associated with medical and psychiatric comorbidities. Until recently, self-help and psychotherapy were the primary treatment options for patients with BED. In early 2015, lisdexamfetamine dimesylate, a prodrug stimulant marketed for attention deficit hyperactive disorder, was the first pharmacologic agent to be approved by the US Food and Drug Administration for the treatment of moderate or severe BED in adults. This article summarizes BED clinical presentation, and discusses the pharmacokinetic profile, efficacy, and safety of lisdexamfetamine dimesylate in the treatment of BED in adults.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LDX inhibits the activity of SERT and MAO, not shared with MPH.
“LDX inhibits the activity of two other important proteins, not shared with MPH, involved in the monoaminergic system described in ADHD: SERT [164] and MAO [165].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [164]
The Pharmacology section says that d-amphetamine, the active metabolite of LDX, is a weak MAO inhibitor. The Pharmacodynamics section says LDX itself is inactive at enzymes in vitro, and the paper does not establish that MAO inhibition is absent with MPH. SERT is separately cited to [164] in the citing sentence, so it is not judged against this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392 · see citing works
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · see citing works
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 1× · see citing works
“Exploratory end-points included assessment of disability with the Sheehan Disability Scale(39) and health-related quality of life (with the EuroQoL 5-dimension 5-level questionnaire).(40) Post hoc analyses were performed to determine the relationship between LDX therapy and disability, BE days per week and disability,…”
(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006 · see citing works
The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication
Hudson, J. I., Hiripi, E., Pope, H. G., & Kessler, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.040 · Cited by 4,973 · see citing works
The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger
Stunkard, A. J., & Messick, S. (1985) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(85)90010-8 · Cited by 4,687 · see citing works
The assessment of binge eating severity among obese persons
Gormally, J., Black, S., Daston, S., & Rardin, D. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90024-7 · Cited by 2,129 · see citing works
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION
Abbas, A., & Aminoroaia, M. (2013) · Cited by 1,478 · see citing works
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440 · see citing works
Ostwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422 · see citing works
Kessler, R. C., Berglund, P. A., Chiu, W. T., Deitz, A. C., Hudson, J. I., Shahly, V., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., Benjet, C., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.020 · Cited by 1,338 · see citing works
Is dopamine a physiologically relevant mediator of feeding behavior?
Palmiter, R. D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.004 · Cited by 469 · see citing works
Vocks, S., Tuschen‐Caffier, B., Pietrowsky, R., Rustenbach, S. J., Kersting, A., & Herpertz, S. (2010) · International Journal of Eating Disorders · doi:10.1002/eat.20696 · Cited by 343 · see citing works
McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., Wang, J., Whitaker, T., Jonas, J., & Gasior, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2162 · Cited by 322 · see citing works
Self-citationEnhanced Striatal Dopamine Release During Food Stimulation in Binge Eating Disorder
Wang, G., Geliebter, A., Volkow, N. D., Telang, F. W., Logan, J., Jayne, M. C., Galanti, K., Selig, P. A., Han, H., Zhu, W., et al. (2011) · Obesity · doi:10.1038/oby.2011.27 · Cited by 313 · see citing works
Hudson, J. I., Lalonde, J. K., Coit, C. E., Tsuang, M. T., McElroy, S. L., Crow, S. J., Bulik, C. M., Hudson, M., Yanovski, J. A., Rosenthal, N. R., et al. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29203 · Cited by 296 · see citing works
Self-citationMcElroy, S. L., Hudson, J., Ferreira-Cornwell, M. C., Radewonuk, J., Whitaker, T., & Gasior, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.275 · Cited by 254 · see citing works
Self-citationCo-Occurrence of Binge Eating Disorder With Psychiatric and Medical Disorders
Javaras, K. N., Pope, H. G., Lalonde, J. K., Roberts, J. L., Nillni, Y. I., Laird, N. M., Bulik, C. M., Crow, S. J., McElroy, S. L., & Walsh, B. T. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0213 · Cited by 241 · see citing works
Self-citationOn speed: the many lives of amphetamine
(2008) · Choice Reviews Online · doi:10.5860/choice.46-2125 · Cited by 177 · see citing works
Medical comorbidity and medical complications associated with binge‐eating disorder
Mitchell, J. E. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22452 · Cited by 162 · see citing works
Atomoxetine in the Treatment of Binge-Eating Disorder
McElroy, S. L., Guerdjikova, A. I., Kotwal, R., Welge, J. A., Nelson, E. B., Lake, K. A., Keck, P. E., & Hudson, J. I. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0306 · Cited by 151 · see citing works
Self-citationApps and eating disorders: A systematic clinical appraisal
Fairburn, C. G., & Rothwell, E. R. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22398 · Cited by 121 · see citing works
Levitan, R. D., Masellis, M., Basile, V. S., Lam, R. W. M., Kaplan, A. S., Davis, C. A., Muglia, P., Mackenzie, B. E., Tharmalingam, S., Kennedy, S. H., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.013 · Cited by 105 · see citing works
Shinohara, M., Mizushima, H., Hirano, M., Shioe, K., Nakazawa, M., Hiejima, Y., Ono, Y., & Kanba, S. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0415 · Cited by 97 · see citing works
Striatal Dopamine in Bulimia Nervosa: a PET Imaging Study
Broft, A., Shingleton, R., Kaufman, J., Liu, F., Kumar, D. J. S., Slifstein, M., Abi-Dargham, A., Schebendach, J., Heertum, R. V. V., Attia, E., et al. (2012) · International Journal of Eating Disorders · doi:10.1002/eat.20984 · Cited by 84 · see citing works
Overview of the treatment of binge eating disorder
McElroy, S. L., Guerdjikova, A. I., Mori, N. N., Munoz, M. R., & Keck, P. E. (2015) · CNS Spectrums · doi:10.1017/s1092852915000759 · Cited by 82 · see citing works
Self-citationJuarascio, A. S., Goldstein, S. P., Manasse, S. M., Forman, E. M., & Butryn, M. L. (2015) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2015.06.004 · Cited by 81 · see citing works
McElroy, S. L., Mitchell, J. E., Wilfley, D. E., Gasior, M., Ferreira‐Cornwell, M. C., McKay, M., Wang, J., Whitaker, T., & Hudson, J. I. (2015) · European Eating Disorders Review · doi:10.1002/erv.2418 · Cited by 76 · see citing works
Self-citationMadhoo, M., Keefe, R. S., Roth, R. M., Sambunaris, A., Wu, J., Trivedi, M. H., Anderson, C. S., & Lasser, R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.334 · Cited by 74 · see citing works
Hutson, P. H., Pennick, M., & Secker, R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.014 · Cited by 72 · see citing works
Modulation of Eating by Central Catecholamine Systems
Wellman, P. J. (2005) · Current Drug Targets · doi:10.2174/1389450053174532 · Cited by 60 · see citing works
Trivedi, M. H., Cutler, A. J., Richards, C., Lasser, R., Geibel, B. B., Gao, J., Sambunaris, A., & Patkar, A. A. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08360 · Cited by 58 · see citing works
Psychopharmacologic Treatment of Eating Disorders: Emerging Findings
McElroy, S. L., Guerdjikova, A. I., Mori, N. N., & Keck, P. E. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0573-1 · Cited by 57 · see citing works
Self-citationEffects of lisdexamfetamine in a rat model of binge-eating
Vickers, S. P., Hackett, D., Murray, F., Hutson, P. H., & Heal, D. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115615107 · Cited by 56 · see citing works
Lasser, R. A., Dirks, B., Nasrallah, H. A., Kirsch, C., Gao, J., Pucci, M. L., Knesevich, M. A., & Lindenmayer, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.111 · Cited by 46 · see citing works
Adjunctive lisdexamfetamine in bipolar depression
McElroy, S. L., Martens, B. E., Mori, N. N., Blom, T. J., Casuto, L., Hawkins, J. M., & Keck, P. E. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000051 · Cited by 43 · see citing works
Self-citationMorrow, S. A., Smerbeck, A., Patrick, K., Cookfair, D., Weinstock-Guttman, B., & Benedict, R. H. B. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6663-7 · Cited by 40 · see citing works
Validation of the yale‐brown obsessive compulsive scale modified for binge eating
Deal, L. S., Wirth, R. J., Gasior, M., Herman, B. K., & McElroy, S. L. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22407 · Cited by 36 · see citing works
Self-citationON SPEED. THE MANY LIVES OF AMPHETAMINE
McKetin, R. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02425_1.x · Cited by 30 · see citing works
Lisdexamfetamine Dimesylate: A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder
Steer, C., Froelich, J., Soutullo, C. A., Johnson, M., & Shaw, M. (2012) · CNS Drugs · doi:10.2165/11634340-000000000-00000 · Cited by 30 · see citing works
Acute methylphenidate treatments reduce sucrose intake in restricted-fed bingeing rats
Bello, N. T., & Hajnal, A. S. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.07.006 · Cited by 29 · see citing works
Atomoxetine in the Treatment of Binge-Eating Disorder: A Randomized Placebo-Controlled Trial
Ballenger, J. C. (2008) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70855-7 · Cited by 11 · see citing works
Pawaskar, M. D., Ágh, T., Radewonuk, J., Vokó, Z., McElroy, S. L., Herman, B., & Gasior, M. (2015) · Value in Health · doi:10.1016/j.jval.2015.09.958 · Cited by 1 · see citing works
Self-citationPawaskar, M. D., Vokó, Z., Ágh, T., Sheehan, D. V., McElroy, S. L., Radewonuk, J., Merész, G., Herman, B., & Gasior, M. (2015) · Value in Health · doi:10.1016/j.jval.2015.09.959 · Cited by 1 · see citing works
Self-citationFactor structure of the Barratt impulsiveness scale
Patton, J. H., Stanford, M. S., & Barratt, E. S. (1995) · Journal of Clinical Psychology · doi:10.1002/1097-4679(199511)51:6
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Eating Disorders and Metabolic Diseases
Yu, Z., & Muehleman, V. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032446 · Cited by 77 · see citing works
Quintero, J., Gutiérrez-Casares, J. R., & Álamo, C. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00392-2 · Cited by 70 · see citing works
Current Discoveries and Future Implications of Eating Disorders
Feng, B. C., Harms, J., Chen, E., Gao, P., Xu, P., & He, Y. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20146325 · Cited by 59 · see citing works
Lisdexamfetamine: A Review in Binge Eating Disorder
Heo, Y., & Duggan, S. T. (2017) · CNS Drugs · doi:10.1007/s40263-017-0477-1 · Cited by 56 · see citing works
İnce, B., Schlatter, J. E., Max, S. M., Plewnia, C., Zipfel, S., Giel, K. E., & Schag, K. (2021) · Journal of Eating Disorders · doi:10.1186/s40337-021-00384-x · Cited by 44 · see citing works
Neural circuit control of innate behaviors
Wei, X., Jiao, Z., Senol, E., Yao, J., Zhao, M., Zhao, Z., Chen, X., Cao, P., Fu, Y., Gao, Z., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-2043-2 · Cited by 38 · see citing works
Fornaro, M., Solmi, M., Perna, G., Berardis, D. D., Veronese, N., Orsolini, L., Ganança, L., & Stubbs, B. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s109637 · Cited by 37 · see citing works
O’Hara, V. M., Curran, J. L., & Browne, N. T. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00410-0 · Cited by 29 · see citing works
Converging vulnerability factors for compulsive food and drug use
Serafine, K. M., O’Dell, L. E., & Zorrilla, E. P. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108556 · Cited by 28 · see citing works
Abdulla, Z. A. R. A., Almahmood, H. O., Alghasra, R. R., Alherz, Z. A. S., Alsharifa, H. A. G., Qamber, S. J., Alomar, N. A., Almajed, F. E., Almahroos, T. R., Alnajjas, Z. A., et al. (2023) · Journal of Eating Disorders · doi:10.1186/s40337-022-00726-3 · Cited by 28 · see citing works
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26 · see citing works
Amodeo, G., Cuomo, A., Bolognesi, S., Goracci, A., Trusso, M. A., Piccinni, A., Neal, S. M., Baldini, I., Federico, E., Taddeucci, C., et al. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1571041 · Cited by 25 · see citing works
Costandache, G., Munteanu, O., Salaru, A., Oroian, B. A., & Cozmin, M. (2023) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2023.127237 · Cited by 24 · see citing works
Cuesto, G., Everaerts, C., León, L. G., & Acebes, Á. (2017) · Journal of Neurogenetics · doi:10.1080/01677063.2017.1353092 · Cited by 23 · see citing works
Abdo, N., Boyd, E., Baboumian, S., Pantazatos, S. P., & Geliebter, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.10.032 · Cited by 18 · see citing works
Vaddadi, S., Czelatka, N., Gutierrez, B. D., Maddineni, B., Torres-Teran, C. D., Tron, D. N., McCall, K. L., & Piper, B. J. (2021) · PeerJ · doi:10.7717/peerj.12619 · Cited by 17 · see citing works
Nutley, S. K., Mathews, C. A., & Striley, C. W. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107907 · Cited by 15 · see citing works
Candela, C. G. (2017) · Nutrición Hospitalaria · doi:10.20960/nh.1562 · Cited by 14 · see citing works
Sun, R., & Yang, X. (2024) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202401172 · Cited by 11 · see citing works
Berger, G., Corris, J. D., Fields, S. E., Hao, L., Scarpa, L. L., & Bello, N. T. (2023) · Biomolecules · doi:10.3390/biom13050742 · Cited by 8 · see citing works
Binge Eating Disorder: A 5-Year Retrospective Study on Experimental Drugs
Levitan, M. N., Papelbaum, M., Carta, M. G., Appolinário, J. C., & Nardi, A. E. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s255376 · Cited by 8 · see citing works
Sioziou, A. L., Lappas, A. S., Skarlatos, M., Mesiari, C., Florou, M. C., Argyrou, A., Christodoulou, G. N., Chourdakis, M., & Samara, M. T. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.03.006 · Cited by 7 · see citing works
Taylor, J. (2019) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2019.09.021 · Cited by 7 · see citing works
Steffen, K. J., Mohammad, A. S., Roerig, J. L., Mitchell, J. E., Nelson, C. A., Orcutt, M. J., Zhang, W., Erickson, A. L., & Elmquist, W. F. (2021) · Obesity Surgery · doi:10.1007/s11695-020-04969-4 · Cited by 7 · see citing works
How pharmacology can aid in the diagnosis of mental disorders
Seifert, R., Schirmer, B., & Seifert, J. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03413-z · Cited by 5 · see citing works
Pharmakotherapie der Essstörungen—Ein Update
Bauman, T., & Voderholzer, U. (2025) · Der Nervenarzt · doi:10.1007/s00115-025-01804-y · Cited by 4 · see citing works
Binge eating disorder hidden behind a wall of anxiety disorders
Pipe, A., Patterson, B. A., & Ameringen, M. V. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200235 · Cited by 4 · see citing works
Zyoud, S. H., Shakhshir, M. H., Abushanab, A. S., Koni, A. A., Shahwan, M. J., Jairoun, A. A., & Al‐Jabi, S. W. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i7.982 · Cited by 4 · see citing works
Gutiérrez-Casares, J. R., Quintero, J., Segú-Vergés, C., Monterde, P. R., Pozo-Rubio, T., Coma, M., & Montoto, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.939650 · Cited by 5 · see citing works
Armanious, A. J., Asare, A., Mitchison, D., & James, M. H. (2024) · Psychiatry Research Communications · doi:10.1016/j.psycom.2024.100195 · Cited by 4 · see citing works
Gutiérrez-Casares, J. R., Segú-Vergés, C., Chueca, J. S., Pozo-Rubio, T., Coma, M., Montoto, C., & Quintero, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1118253 · Cited by 3 · see citing works
Current Pharmacological Treatments for Childhood-Onset Eating Disorders
Campbell, J., Ramirez, N., & Derenne, J. L. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-019-00189-5 · Cited by 3 · see citing works
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA
Alexander, G. D., Cavanah, L. R., Goldhirsh, J. L., Huey, L. Y., & Piper, B. J. (2023) · Pharmacopsychiatry · doi:10.1055/a-2152-7757 · Cited by 2 · see citing works
Brucar, L. R., Hyder, A., & Birmingham, C. L. (2018) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2018.82014 · Cited by 2 · see citing works
Assessment of Binge-Like Eating of Unsweetened vs. Sweetened Chow Pellets in BALB/c Substrains
Sena, K. D., Beierle, J. A., Richardson, K. T., Kantak, K. M., & Bryant, C. D. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.944890 · Cited by 2 · see citing works
Dufour, R., Shalev, U., & Booij, L. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04035-0 · Cited by 1 · see citing works
Pharmacologic Treatment of Obesity
Latif, F., Cho, J., & Hornack, S. E. (2016) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2016.21.2.1 · Cited by 1 · see citing works
Eating Disorder: Influences of Hormones and Vitamins
Islam, S. (2016) · Advances in Obesity Weight Management & Control · doi:10.15406/aowmc.2016.05.00119 · Cited by 1 · see citing works
Repurposed Drugs of Abuse (Stimulants, Ketamine, and Psychedelics): Focus on Risks
Souza‐Marques, B., Caliman‐Fontes, A. T., Leal, G. C.-G., Bandeira, I. D., Mello, R. P., Alves-Pereira, R., & Quarantini, L. C. (2025) · Springer eBooks · doi:10.1007/978-3-031-85519-1_28
Colón-Rivera, H., & Fischer, K. K. (2026) · Springer eBooks · doi:10.1007/978-3-032-24174-0_14
- Authors
- Guerdjikova, A. I., Mori, N., Casuto, L. S., & McElroy, S. L.
- Affiliations
- Lindner Center of HOPE (US)
- Corresponding author
- Guerdjikova, Anna I.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2016-04
- Volume
- 12
- Pages
- 833
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC4841437
- OpenAlex
- W2339283192
- Cited by
- 40
- References
- 48
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 3 · 2021: 7 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 3
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Nutrition, Health and Food Behavior
- Keywords
- binge eating disorder, lisdexamfetamine dimesylate, pharmacotherapy, stimulant medication, pharmacokinetics, treatment efficacy, drug safety, FDA approval, eating disorders in adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
